Last reviewed · How we verify

NCT04238897

To Evaluate the Efficacy and Safety of Aspherical Soft Contact Lens in Myopia Control

Completed NA Last updated 23 January 2020
What this trial tests

NA trial testing soft contact lens in Myopia in 72 participants. Completed in 6 June 2019.

Timeline
4 May 2016
Primary endpoint
12 September 2018
6 June 2019

Quick facts

Lead sponsorAPP Vision Care Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment72
Start date4 May 2016
Primary completion12 September 2018
Estimated completion6 June 2019

Drugs / interventions tested

Conditions studied

Sponsor

APP Vision Care Inc.

Who can join

Adults 9 to 15, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to demonstrate that the Ticon Aspherical Daily Disposable Soft Contact Lens could retard myopia progress in youth

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Interventions for myopia control in children: a living systematic review and network meta-analysis.
    Lawrenson JG, Shah R, Huntjens B, Downie LE, et al · · 2023 · cited 117× · PMID 36809645 · DOI 10.1002/14651858.cd014758.pub2
  2. Center-for-Near Extended-Depth-of-Focus Soft Contact Lens for Myopia Control in Children: 1-Year Results of a Randomized Controlled Trial.
    Shen EP, Chu HS, Cheng HC, Tsai TH. · · 2022 · cited 17× · PMID 35737291 · DOI 10.1007/s40123-022-00536-5

Verify or expand the search:

Other trials of soft contact lens

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04238897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing